Latest News in the pharma Industry

Biopharma News

Is COVID-19 the catalyst for Western pharma markets to revert to domestic API production?

Is COVID-19 the catalyst for Western pharma markets to revert to domestic API production?

7 May 2020

The ongoing pandemic has fuelled debate about whether Western pharmaceutical supply chains and API sourcing are too dependent on lower-cost Asian suppliers such as China. Do the US and Europe need to bring manufacturing back home?

Read more 
Evonik launches European API manufacturing capacity expansion programme

Evonik launches European API manufacturing capacity expansion programme

6 May 2020

EUR 25 million first stage expected to be completed by mid-2021 as COVID-19 pandemic highlights need for more European capacity

Read more 
Gilead outlines plans for global expansion of remdesivir production

Gilead outlines plans for global expansion of remdesivir production

6 May 2020

Biotech in discussions with pharmaceutical and chemical manufacturers on how to broaden supply of antiviral that last week received an emergency use authorization for treatment of COVID-19 from the FDA

Read more 
Bio-Rad launches anti-certolizumab pegol antibodies

Bio-Rad launches anti-certolizumab pegol antibodies

5 May 2020

Using this critical antibody reagent at the preclinical stage of development will minimize the need to revalidate assays with different reagents at the clinical development stage.

Read more 
Univercells launches new subsidiary called Univercells Technologies

Univercells launches new subsidiary called Univercells Technologies

5 May 2020

The new business unit will focus on existing automated biomanufacturing products, as well as launching new technologies.

Read more 
Sartorius closes acquisition of selected assets of Danaher Life Sciences

Sartorius closes acquisition of selected assets of Danaher Life Sciences

4 May 2020

The addition of various laboratory and bioprocessing technologies will support customers to develop biotech medicines and vaccines.

Read more 
Moderna signs up Lonza to boost scale-up of mRNA vaccine for coronavirus

Moderna signs up Lonza to boost scale-up of mRNA vaccine for coronavirus

4 May 2020

Collaboration leverages CDMO’s expertise in tech transfer and manufacturing to aim for 1 million doses per day

Read more 
Scaling up and speeding up: pharma’s manufacturing challenges during COVID-19

Scaling up and speeding up: pharma’s manufacturing challenges during COVID-19

1 May 2020

As biopharma searches for vaccines and treatments to alleviate the crisis, how can companies manage shortened timelines to rapidly develop and manufacture safe and effective products on a global scale? A recent Endpoints webinar sheds some light

Read more 
Strides starts exports of generic version of Avigan for COVID-19 treatment

Strides starts exports of generic version of Avigan for COVID-19 treatment

29 Apr 2020

Antiviral drug has been developed in-house with API manufacturer signed up to secure KSM

Read more 
Merck KGaA to double viral vector capacity through EUR 100 million Carlsbad expansion

Merck KGaA to double viral vector capacity through EUR 100 million Carlsbad expansion

21 Apr 2020

Second 140,000 square-foot facility is expected to open next year

Read more 
How drug delivery and device manufacturers can capitalise on the biologics boom

How drug delivery and device manufacturers can capitalise on the biologics boom

17 Apr 2020

The biologics market is Pharma’s fastest growing market. With such significant growth of a different breed of products, what are the opportunities and implications for pharma packaging and drug delivery manufacturers?

Read more 
Nitrosamine contamination: pharma’s re-evaluation of its supply chain

Nitrosamine contamination: pharma’s re-evaluation of its supply chain

17 Apr 2020

The detection of nitrosamine impurities in some finished dosages has opened up a whole new set of challenges for API manufacturers who need to perform risk evaluations of their processes

Read more